首页> 外国专利> IN VIVO SELECTIVE TUMOR SUPPRESSING METHOD USING LAYERED DIHYDROXIDE WHICH MAXIMIZES DRUG EFFECT AND MINIMIZES SIDE EFFECTS

IN VIVO SELECTIVE TUMOR SUPPRESSING METHOD USING LAYERED DIHYDROXIDE WHICH MAXIMIZES DRUG EFFECT AND MINIMIZES SIDE EFFECTS

机译:层状二氧化氢的体内选择性肿瘤抑制方法,该方法最大程度地减轻了药物的作用,并使副作用最小化

摘要

PURPOSE: An in vivo selective tumor suppressing method using layered dihydroxide is provided to selectively transfer anti-cancer drug to cancer tissue and prevent reduction of efficiency.;CONSTITUTION: An in vivo selective tumor suppressing method using layered dihydroxide is performed by transferring to cancer cells and increasing residence time in the body compared with administering anti-cancer drug only. A composition of LDH and anti-cancer drug has targeting function of effectively treating cancer without any side effect. The cancer is osteosarcoma. The composite of the LDH and anti-cancer drug is manufactured in 50-450 nm by hydrothermal reaction.;COPYRIGHT KIPO 2010
机译:目的:提供一种利用层状二氢氧化物的体内选择性肿瘤抑制方法,以选择性地将抗癌药物转移至癌组织并防止效率降低。;组成:通过分层转移至癌细胞中进行体内选择性肿瘤抑制方法与仅服用抗癌药相比,其在体内的停留时间更长。 LDH和抗癌药的组合物具有有效地治疗癌症而没有任何副作用的靶向功能。癌症是骨肉瘤。通过水热反应在50-450 nm下生产LDH和抗癌药的复合材料。; COPYRIGHT KIPO 2010

著录项

  • 公开/公告号KR20090102996A

    专利类型

  • 公开/公告日2009-10-01

    原文格式PDF

  • 申请/专利权人 NANOHYBRID CO. LTD.;

    申请/专利号KR20080028305

  • 发明设计人 KANG MUN SIK;

    申请日2008-03-27

  • 分类号A61K31/505;A61P35/00;

  • 国家 KR

  • 入库时间 2022-08-21 19:12:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号